Build status - In Progress

Study Evaluating the Safety and tolerability of AMG 757 and determine the maximum tolerated dose

Study Evaluating the Safety and tolerability of AMG 757 and determine the maximum tolerated dose
Recruiting
18 years - 99 years
Male
Phase N/A
8 participants needed
1 Location

Brief description of study

The purpose of this study is to obtain initial information on the safety and tolerability (effects good or bad) of a short-term intravenous (IV) infusion of AMG 757 for the treatment of neuroendocrine prostate cancer (a certain type of prostate cancer). This study will also look at what doses of AMG 757 are safe for people to take.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Prostatic Neoplasms,Genital Neoplasms Male,Urogenital Neoplasms
  • Age: 18 years - 99 years
  • Gender: Male

Men aged ≥ 18 years Prostate Cancer

Updated on 04 Aug 2024. Study ID: 849292

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center